DRC & Research News

This page shares the latest news in T1D research and DRC’s community.

Get the most recent diabetes research news, delivered straight to your inbox

Infancy Diabetes Risk

Predicting Diabetes Risk in Infancy

Type 1 diabetes (T1D) is a chronic condition that often develops in early childhood, though it can present later in life for some. Researchers believe that it stems from a variety genetic and environmental risk factors. Oftentimes individuals do not realize they have T1D until they experience an episode of hyperglycemia or diabetic ketoacidosis. These are serious and potentially life-threatening conditions that must be treated immediately.

Recognizing risk factors early on can help doctors to be proactive and better manage children’s health to reduce complications. A recent study from The Environmental Determinants of Diabetes in the Young (TEDDY) involved 7,798 children from around the world who were identified as being at high risk of developing T1D. The study followed them for nine years, starting at birth, and assigned participants a risk score based on “genetics, clinical factors such as family history of diabetes, and their count of islet autoantibodies – biomarkers known to be implicated in type 1 diabetes.”

This approach improved newborn screenings and the ability to predict the development of T1D. In addition, it allowed doctors to educate families about the disease early on. By more accurately assessing risk, researchers can target clinical trials for preventing the disease to those children who may benefit most. Early detection also allows for improved treatment and management of the disease from the start, which may reduce complications.

Recognizing risk of type 1 diabetes and developing effective prevention strategies is essential. Researchers are continually advancing their knowledge and testing different therapies and approaches to slow or stop T1D. This is an exciting step forward in prevention and treatment efforts. The Diabetes Research Connection (DRC) is interested to see how this study could influence diabetes management.

Research across all stages of the disease is critical. The DRC empowers early-career scientists to pursue novel, peer-reviewed research studies focused on type 1 diabetes by providing key funding. One hundred percent of research funds go directly to the scientists. To learn more about current projects and how to help, visit https://diabetesresearchconnection.org.

Please DONATE NOW so DRC can keep bringing you credible, peer-reviewed T1D news and research.

Thank you

Learn More +


See our approved research projects and campaigns.

Role of the integrated stress response in type 1 diabetes pathogenesis
In individuals with type 1 diabetes (T1D), the insulin-producing beta cells are spontaneously destroyed by their own immune system. The trigger that provokes the immune system to destroy the beta cells is unknown. However, accumulating evidence suggest that signals are perhaps first sent out by the stressed beta cells that eventually attracts the immune cells. Stressed cells adapt different stress mitigation systems as an adaptive response. However, when these adaptive responses go awry, it results in cell death. One of the stress response mechanisms, namely the integrated stress response (ISR) is activated under a variety of stressful stimuli to promote cell survival. However, when ISR is chronically activated, it can be damaging to the cells and can lead to cell death. The role of the ISR in the context of T1D is unknown. Therefore, in this DRC funded study, we propose to study the ISR in the beta cells to determine its role in propagating T1D.
Wearable Skin Fluorescence Imaging Patch for the Detection of Blood Glucose Level on an Engineered Skin Platform
A Potential Second Cure for T1D by Re-Educating the Patient’s Immune System
L Ferreira
Validating the Hypothesis to Cure T1D by Eliminating the Rejection of Cells From Another Person by Farming Beta Cells From a Patient’s Own Stem Cells
Han Zhu
Taming a Particularly Lethal Category of Cells May Reduce/Eliminate the Onset of T1D
JRDwyer 2022 Lab 1
Can the Inhibition of One Specific Body Gene Prevent Type 1 Diabetes?
Is Cholesterol Exacerbating T1D by Reducing the Functionality and Regeneration Ability of Residual Beta Cells?
Regeneration Ability of Residual Beta Cells
A Call to Question… Is T1D Caused by Dysfunctionality of Two Pancreatic Cells (β and α)?
Xin Tong
Novel therapy initiative with potential path to preventing T1D by targeting TWO components of T1D development (autoimmune response and beta-cell survival)
flavia pecanha